![Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]](https://megaphone.imgix.net/podcasts/cbc5538c-3d2c-11f1-abeb-8fa0b9345ba8/image/7338c7270d70078f65b4911eb9cd5b0b.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress)
Alex Karnal - The Trillion-Dollar Health Revolution - [Invest Like the Best, EP.468]
From Invest Like the Best with Patrick O'Shaughnessy by Colossus | Investing & Business Podcasts
April 21, 2026 · 1h 32m · Episode 485
About this episode
Alex Karnal discusses the health stack and the future of proactive health strategies in drug discovery.
My guest today is Alex Karnal. Alex is the co-founder and managing partner of Braidwell, a life sciences investment firm he built after spending 15 years at Deerfield Management. The frame we use throughout the episode is the health stack. Alex talks about how most of the diseases that will claim most of our lives are already addressable with medicines that exist today. We work through the five layers of what a defensive health strategy looks like, why GLP-1 medicines represent the first commercial proof that people are ready to be proactive about their health, and why PCSK9 inhibitors may ultimately be the more important drug class even though they get far less attention. We also get into the science and business of drug discovery itself — why most of the published literature that AI companies are training on cannot be replicated, what it would mean to have a truly agentic scientific lab running 24 hours a day, and why Alex believes we are now on a deterministic curve toward scientific superintelligence in biology. For the full show notes, transcript, and links to mentioned content, check out the episode page here. ----- Become a Colossus member to get our…
People in this episode
Host: Patrick O'Shaughnessy
Guest: Alex Karnal
Topics covered
- health stack
- defensive health strategy
- drug discovery
- AI in biology
- proactive health
Keywords
- health revolution
- life sciences
- medicines
- scientific superintelligence
- disease management
Mentioned in this episode
Organizations: Braidwell, Deerfield Management, AI companies
Products: GLP-1 medicines, PCSK9 inhibitors
More episodes of Invest Like the Best with Patrick O'Shaughnessy
- Alex Sacerdote - How to Invest Through Technology Cycles - [Invest Like the Best, EP.477] · June 9, 2026 · 1h 11m
- Dara Khosrowshahi - Uber's Bet on AVs, AI, and Building a Super-App - [Invest Like the Best, EP.476] · June 3, 2026 · 1h 7m
- Dan Loeb - Lessons from 30 Years of Investing - [Invest Like the Best, EP.475] · May 28, 2026 · 1h 3m
- Darren Farber on Iran, China, and the Rise of Neoprimes - [Invest Like the Best, EP.474] · May 26, 2026 · 46 min
- Gavin Baker - Watts and Wafers - [Invest Like the Best, EP.473] · May 20, 2026 · 1h 17m
- Krishna Rao - Anthropic's CFO on Compute, Scaling to $30B ARR, and the Returns to Frontier Intelligence - [Invest Like the Best, EP.472] · May 13, 2026 · 1h 16m
Explore listener stats, chart rankings, contacts and more on the Invest Like the Best with Patrick O'Shaughnessy podcast page.